Could Targeting the Heat Shock Protein 90 Revolutionize Antiviral therapy?

References

• Anderson I , LowJS, WestonSet al. Heat shock protein 90 controls HIV-1 reactivation from latency . Proc. Natl Acad. Sci. USA111 ( 15 ), 1528 – 1537 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Burch AD , WellerSK . Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone Hsp90 for proper localization to the nucleus . J. Virol.79 ( 16 ), 10740 – 10749 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Shim HY , QuanX, YiYSet al. Heat shock protein 90 facilitates formation of the HBV capsid via interacting with the HBV core protein dimers . Virology410 ( 1 ), 161 – 169 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Clercq ED , HerdewijnP . Strategies in the design of antiviral drugs . Nat. Rev. Drug Discov.1 ( 1 ), 13 – 25 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Global Report on Early Warning Indicators of HIV Drug Resistance: Technical Report . WHO, Geneva, Switzerland ( 2016 ).
   Google Scholar
• Sun X , BristolJA, IwahoriSet al. Hsp90 Inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein–Barr virus-infected cells . J. Virol.8 ( 18 ), 10126 – 10138 ( 2013 ).
   Google Scholar
• Zhong M , ZhengK, ChenMet al. Heat-shock protein 90 promotes nuclear transport of herpes simplex virus 1 capsid protein by interacting with acetylated tubulin . PLoS ONE9 ( 6 ), e99425 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Li YH , TaoPZ, LiuYZet al. Geldanamycin, a ligand of heat shock protein 90, inhibits the replication of herpes simplex virus type 1 in vitro . Antimicrob. Agents Chemother.48 ( 3 ), 867 – 872 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Mimnaugh EG , ChavanyC, NeckersL . Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin . J. Biol. Chem.271 ( 37 ), 22796 – 22801 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Schneider C , SepplorenzinoL, NimmesgernEet al. Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90 . Proc. Natl Acad. Sci. USA93 ( 25 ), 14536 – 14541 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Chen B , PielWH, GuiLet al. The HSP90 family of genes in the human genome: insights into their divergence and evolution . Genomics86 ( 6 ), 627 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Song HL , RanS, MiNLet al. A molecular chaperone glucose-regulated protein 94 blocks apoptosis induced by virus infection . Hepatology47 ( 3 ), 854 – 866 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Liu D , WuAD, CuiLet al. Hepatitis B virus polymerase suppresses NF-κB signaling by inhibiting the activity of IKKs via interaction with Hsp90β . PLoS ONE9 ( 3 ), e91658 – e91658 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sherry B , ZybarthG, AlfanoMet al. Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes . Proc. Natl Acad. Sci. USA95 ( 4 ), 1758 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Silverstein AM , GalignianaMD, ChenMSet al. Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin . J. Biol. Chem.272 ( 26 ), 16224 – 16230 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Guo Y , GuettoucheT, FennaMet al. Evidence for a mechanism of repression of heat shock factor 1 transcriptional activity by a multichaperone complex . J. Biol. Chem.276 ( 49 ), 45791 – 45799 ( 2002 ).
   Web of Science ®Google Scholar
• Zhang M , WindheimM, RoeSMet al. Chaperoned ubiquitylation – crystal structures of the CHIP U Box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex . Mol. Cell20 ( 4 ), 525 – 538 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Triantafilou K , TriantafilouM, DedrickRL . A CD14-independent LPS receptor cluster . Nat. Immunol.2 ( 4 ), 338 – 346 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Stewart S , SundaramM, ZhangYet al. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization . Mol. Cell. Biol.19 ( 8 ), 5523 – 5534 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Eckl JM , RutzDA, HaslbeckV, ZiererBK, ReinsteinJ, RichterK . Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites . J. Biol. Chem.288 ( 22 ), 16032 – 16042 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Woodford MR , DunnDM, BlandenARet al. The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding . Nat. Comm.7, 12037 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Walerych D , GutkowskaM, KlejmanMPet al. ATP binding to Hsp90 is sufficient for effective chaperoning of p53 protein . J. Biol. Chem.285 ( 42 ), 32020 – 32028 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y , WangJS, ChenLLet al. Repression of hsp90beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells . J. Biol. Chem.279 ( 41 ), 42545 – 42551 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Miyata Y , YaharaI . p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, Hsp90 . Oncogene19 ( 11 ), 1477 – 1484 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Mahony D , ParryDA, LeesE . Active CDK6 complexes are predominantly nuclear and represent only a minority of the CDK6 in T cells . Oncogene16 ( 5 ), 603 – 611 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Chadli A , GrahamJD, AbelMGet al. GCUNC-45 is a novel regulator for the progesterone receptor/Hsp90 chaperoning pathway . Mol. Cell. Biol.26 ( 5 ), 1722 – 1730 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Moffatt NSC , BruinsmaE, UhlCet al. Role of the cochaperone Tpr2 in Hsp90 chaperoning . Biochemistry47 ( 31 ), 8203 – 8213 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wu B , LiP, LiuYet al. 3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex . Proc. Natl Acad. Sci. USA101 ( 22 ), 8348 – 8353 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Sciacovelli M , GuzzoG, MorelloVet al. The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase . Cell Metab.17 ( 6 ), 988 – 999 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hu J , TanEY, CampoLet al. TRAP1 is involved in cell cycle regulated by retinoblastoma susceptibility gene (RB1) in early hypoxia and has variable expression patterns in human tumors . J. Cancer Res. Update2, 194 – 210 ( 2013 ).
   Google Scholar
• Yoshida S , TsutsumiS, MuhlebachGet al. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis . Proc. Natl Acad. Sci. USA110 ( 17 ), e1604 – e1612 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kim G , HanJM, KimS . Toll-like receptor 4-mediated c-Jun N-terminal kinase activation induces gp96 cell surface expression via AIMP1 phosphorylation . Biochem. Biophys. Res. Commun.397 ( 1 ), 100 – 105 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Christianson JC , ShalerTA, TylerREet al. OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD . Nat. Cell Biol.10 ( 3 ), 272 – 282 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Liu B , YangY, QiuZet al. Erratum: folding of toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone . Nat. Commun.3 ( 3 ), 1 – 10 ( 2012 ).
   Google Scholar
• Cloutier P , LavalléeadamM, FaubertDet al. A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity . PLoS Genet.9 ( 1 ), 51 – 62 ( 2013 ).
   Web of Science ®Google Scholar
• Kawashima D , KandaT, MurataTet al. Nuclear transport of Epstein–Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90 . J. Virol.87 ( 11 ), 6482 – 6491 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sun X , KenneySC . Hsp90 inhibitors: a potential treatment for latent EBV infection?Cell Cycle9 ( 9 ), 1665 – 1666 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Hung CY , TsaiMC, WuYPet al. Identification of heat-shock protein 90 beta in Japanese encephalitis virus-induced secretion proteins . J. Gen. Virol.92 ( Pt 12 ), 2803 – 2809 ( 2011 ).
   PubMedGoogle Scholar
• Smith DR , McCarthyS, ChrovianAet al. Inhibition of heat-shock protein 90 reduces Ebola virus replication . Antiviral Res.87 ( 2 ), 187 – 194 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bukong TN , Momen-HeraviF, KodysKet al. Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90 . PLoS Pathog.10 ( 10 ), e1004424 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Thery C , ZitvogelL, AmigorenaS . Exosomes: composition biogenesis and function . Nat. Rev. Immunol.2 ( 8 ), 569 – 579 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Keryerbibens C , PiochedurieuC, VillemantCet al. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9 . BMC Cancer6 ( 1 ), 1 – 8 ( 2006 ).
   PubMedGoogle Scholar
• Yang Y , HanQ, HouZet al. Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction . Cell. Mol. Immunol.14 ( 5 ), 456 – 475 ( 2016 ).
   Web of Science ®Google Scholar
• Momose F , NaitoT, YanoKet al. Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis . J. Biol. Chem.277 ( 47 ), 45306 – 45314 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Naito T , MomoseF, KawaguchiAet al. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits . J. Virol.81 ( 3 ), 1339 – 1349 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Panella S , MarcocciME, CelestinoIet al. MC1568 inhibits HDAC6/8 activity and influenza A virus replication in lung epithelial cells: role of Hsp90 acetylation . Future Med. Chem.8 ( 17 ), 2017 – 2031 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chase G , TaoD, FodorEet al. Hsp90 inhibitors reduce influenza virus replication in cell culture . Virology377 ( 2 ), 431 – 439 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Vendeville A , RayneF, BonhoureAet al. HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses . Mol. Biol. Cell15 ( 5 ), 2347 – 2360 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Vozzolo L , LohB, GanePJet al. Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein . J. Biol. Chem.285 ( 50 ), 39314 – 39328 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bukong TN , HouW, KodysK, SzaboG . Ethanol facilitates hepatitis C virus replication via up-regulation of GW182 and heat shock protein 90 in human hepatoma cells . Hepatology57 ( 1 ), 70 – 80 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Okamoto T , NishimuraY, IchimuraTet al. Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90 . EMBO J.25 ( 20 ), 5015 – 5025 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Taguwa S , OkamotoT, AbeTet al. Human butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replication . J. Virol.82 ( 6 ), 2631 – 2641 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Okamoto T , OmoriH, KanameYet al. A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication . J. Virol.82 ( 7 ), 3480 – 3489 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Waxman L , WhitneyM, PollokBAet al. Host cell factor requirement for hepatitis C virus enzyme maturation . Proc. Natl Acad. Sci. USA98 ( 24 ), 13931 – 13935 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Hu J , FloresD, ToftDet al. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function . J. Virol.78 ( 23 ), 13122 – 13131 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Hu J , SeegerC . Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase . Proc. Natl Acad. Sci. USA93 ( 3 ), 1060 – 1064 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Hu J , AnselmoD . In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90 . J. Virol.74 ( 24 ), 11447 – 11455 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Wang X , GrammatikakisN, HuJ . Role of p50/CDC37 in hepadnavirus assembly and replication . J. Biol. Chem.277 ( 27 ), 24361 – 24367 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Das I , BasantrayI, MamidiPet al. Heat shock protein 90 positively regulates Chikungunya virus replication by stabilizing viral non-structural protein nsP2 during infection . PLoS ONE9 ( 6 ), e100531 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Rathore APS , HaysteadT, DasPKet al. Chikungunya virus nsP3 & nsP4 interacts with Hsp-90 to promote virus replication: Hsp-90 inhibitors reduce CHIKV infection and inflammation in vivo . Antiviral Res.103 ( 1 ), 7 – 16 ( 2014 ).
   PubMedGoogle Scholar
• Ehrenkranz NJ , MeyerKF . Multi-faceted proteomic characterization of host protein complement of rift valley fever virus virions and identification of specific heat shock proteins, including Hsp90, as important viral host factors . PLoS ONE9 ( 5 ), e93483 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Geller R , VignuzziM, AndinoRet al. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractor . Genes Dev.21 ( 2 ), 195 – 205 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Chen W , SinSH, WenKWet al. Hsp90 inhibitors are efficacious against Kaposi sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins . PLoS Pathog.8 ( 11 ), 276 – 287 ( 2012 ).
   Web of Science ®Google Scholar
• Geller R , AndinoR, FrydmanJ . Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus . PLoS ONE8 ( 2 ), ( 2013 ).
   Web of Science ®Google Scholar
• Vashist S , UrenaL, Gonzalez-HernandezMBet al. Molecular chaperoneHhsp90 is a therapeutic target for noroviruses . J. Virol.89 ( 12 ), 6352 – 6363 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Connor JH , McKenzieMO, ParksGDet al. Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses . Virology362 ( 1 ), 109 – 119 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Gao L , HarhajEW . HSP90 Protects the human T-cell leukemia virus type 1 (HTLV-1) tax oncoprotein from proteasomal degradation to support NF-κB activation and HTLV-1 replication . J. Virol.87 ( 24 ), 13640 – 13654 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Czar MJ , GalignianaMD, SilversteinAM, PrattWB Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus . Biochemistry36 ( 25 ), 7776 – 7785 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Tsou YL , LinYW, ChangHWet al. Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy . PLoS ONE8 ( 10 ), e77133 – e77133 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• MacLean CA , DolanA, JamiesonFEet al. The myristylated virion proteins of herpes simplex virus type 1: investigation of their role in the virus life cycle . J. Gen. Virol.73 ( Pt 3 ), 539 – 547 ( 1992 ).
   PubMedGoogle Scholar
• Baba M , NishimuraO, KanzakiNet al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity . Proc. Natl Acad. Sci. USA96 ( 10 ), 5698 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Dragic T , TrkolaA, ThompsonDADet al. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5 . Proc. Natl Acad. Sci. USA97 ( 10 ), 5639 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• De-Clercq E . The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection 1 . Antiviral Res.38 ( 3 ), 153 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Ren J , NicholsC, BirdLEet al. Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding . J. Biol. Chem.275 ( 19 ), 14316 – 14320 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Erickson JW , BurtSK . Structural mechanisms of HIV drug resistance . Ann. Rev. Pharmacol. Toxicol.36 ( 36 ), 545 ( 1996 ).
   PubMedGoogle Scholar
• Hazuda DJ , MillerMD . Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells . Science287 ( 5453 ), 646 – 650 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Wai JS , EgbertsonMS, PayneLSet al. 4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells . J. Med. Chem.43 ( 26 ), 4923 – 4926 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Hayden FG , TreanorJJ, FritzRSet al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment . JAMA282 ( 13 ), 1240 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Sidwell RW , SmeeDF, HuffmanJHet al. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201 . Antimicrob. Agents Chemother.45 ( 3 ), 749 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Nicholson KG , AokiFY, OsterhausADet al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group . Lancet355 ( 9218 ), 1845 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Smee DF , HuffmanJH, MorrisonACet al. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities . Antimicrob. Agents Chemother.45 ( 3 ), 743 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Bantia S , ParkerCD, AnanthSLet al. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir . Antimicrob. Agents Chemother.45 ( 4 ), 1162 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Rice JW , VealJM, FaddenRPet al. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis . Arthritis Rheum.58 ( 12 ), 3765 – 3775 ( 2008 ).
   PubMedGoogle Scholar
• Nakagawa SI , UmeharaT, MatsudaCet al. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice . Biochem. Biophys. Res. Commun.353 ( 4 ), 882 – 888 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Sellers RP , AlexanderLD, JohnsonVAet al. Design and synthesis of Hsp90 inhibitors: exploring the SAR of sansalvamide A derivatives . Bioorg. Med. Chem.18 ( 18 ), 6822 – 6856 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Crotty S , MaagD, ArnoldJJet al. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen . Nat. Med.6 ( 12 ), 1375 – 1379 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Saracco G , OliveroA, CiancioAet al. A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy . J. Hepatol.34 ( 1 ), 133 – 138 ( 2001 ).
   Google Scholar
• Xiang YF , QianCW, XingGWet al. Anti-herpes simplex virus efficacies of 2-aminobenzamide derivatives as novel HSP90 inhibitors . Bioorg. Med. Chem. Lett.22 ( 14 ), 4703 – 4706 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Cowen LE , LindquistS . Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi . Science309 ( 5744 ), 2185 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Holmberg SD , StewartJA, GerberARet al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection . JAMA259 ( 7 ), 1048 ( 1988 ).
   PubMed Web of Science ®Google Scholar
• Solit DB , ZhengFF, DrobnjakMet al. 17-allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts . Clin. Cancer Res.8 ( 5 ), 986 – 993 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Liao ZY , ZhenYS . [Advances in antitumor activity of the hsp90 inhibitor geldanamycin] . Yao Xue Xue Bao: Acta Pharmaceutica Sinica36 ( 9 ), 716 – 720 ( 2001 ).
   PubMedGoogle Scholar
• Jez JM , ChenJC, RastelliGet al. Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90 . Chem. Biol.10 ( 4 ), 361 – 368 ( 2003 ).
   PubMedGoogle Scholar
• Shen G , WangM, AndTRWet al. Design, synthesis, and structure activity relationships for chimeric inhibitors of Hsp90 . J. Organ. Chem.71 ( 20 ), 7618 – 7631 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Roe SM , ObrienR, LadburyJEet al. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin . J. Med. Chem.42 ( 2 ), 260 – 266 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Schumacher JA , CrockettDK, Elenitoba-JohnsonKSet al. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells . Proteomics7 ( 15 ), 2603 – 2616 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Joshi P , MaidjiE, StoddartCA . Inhibition of heat shock protein 90 prevents HIV rebound . J. Biol. Chem.291 ( 19 ), 10332 – 10346 ( 2016 ).
   PubMed Web of Science ®Google Scholar